Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Farhang, Rezaei"'
Autor:
Batool Hossein Rashidi, Khashayar Sayyari, Ramin Heshmat, Saeid Amanpour, Ensieh Shahrokh Tehraninejad, Masoumeh Masoumi, Farhang Rezaei
Publikováno v:
International Journal of Reproductive BioMedicine, Vol 19, Iss 11, Pp 1015-1024 (2021)
Abstract Background: Advances in recombinant DNA technology led to the development of recombinant follitropin alfa. Recombinant human follicle-stimulating hormone products are used to stimulate follicular maturation. Objective: To compare the efficac
Externí odkaz:
https://doaj.org/article/1b1778aca38b4976b884ca402501418b
Autor:
Farhang Rezaei, Nassim Anjidani
Publikováno v:
Generics and Biosimilars Initiative Journal. 10:100-106
Background The advent of follow-on biologicals in Iran and biosimilars worldwide have provided various treatment options for several severe and chronic diseases. The goal of the present study was to provide an overview of their current status in Iran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64ff0a2df4f6cafe66d74aa621f029ec
https://doi.org/10.5639/gabij.2021.1002.010
https://doi.org/10.5639/gabij.2021.1002.010
Autor:
Mehdi, Gharghabi, Farhang, Rezaei, Fereshteh, Mir Mohammadrezaei, Mohammad Hossein, Ghahremani
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
Cyclooxygenase-2 (COX-2) has a pivotal role in the pathogenesis of the lung cancer. It is known that COX-2 negatively regulates the activity of a number of tumor suppressors, including p53. Consequently, inhibition of COX-2 signaling is anticipated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e80e09127c7dc80e2979a252a44bf2b
https://pubmed.ncbi.nlm.nih.gov/27642319
https://pubmed.ncbi.nlm.nih.gov/27642319